Phaco-Trabeculotomy Vs Phaco-Trabeculectomy
Launched by ASSIUT UNIVERSITY · Dec 20, 2020
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Patients were randomized into two groups: group A : patients will undergo two site phacoemulfication combined with trabeculectomy Group B with Phacoemulsification combined with ab-externo trabeculotomy. Preoperative assessments including full ophthalmic examination, anterior segment Optical Coherence Tomography (OCT) of the angle , endothelial cell count , visual fiend Perimetry and Biometry. Patients were followed up: first day, first week and every two months for 6 month. We will compare adverse effects and outcomes in both groups.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with chronic angle closure glaucoma, with or without peripheral anterior synechiae, age more than 18
- Exclusion Criteria:
- • Patient unable for follow up
- • Patients with corneal or retinal disease that affects visual outcome of surgery
- • Patients with previous glaucoma procedure in the eye of study
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials